Hypermarcas (OTCMKTS:HYPMY – Get Free Report) shares saw unusually-high trading volume on Monday . Approximately 11,902 shares changed hands during trading, an increase of 80% from the previous session’s volume of 6,600 shares.The stock last traded at $4.2976 and had previously closed at $4.32.
Hypermarcas Price Performance
The company has a 50 day moving average of $4.55 and a 200 day moving average of $4.47. The stock has a market capitalization of $2.64 billion, a price-to-earnings ratio of 18.13 and a beta of 0.72. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. The company had revenue of $408.83 million during the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Further Reading
- Five stocks we like better than Hypermarcas
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- This stock gets a 94 out of 100
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
